Phreesia (PHR) Stock: Buy, Sell, or Hold?
PHR - Phreesia, Inc.
$10.07
-0.29 (-2.80%)
▼
5d:
-0.79%
30d:
-15.02%
90d:
-9.28%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Sep 02, 2026
0d
Get Alerted When PHR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PHR shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: PHR shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$26.10
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$16.21
37.9% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PHR is currently trading at $10.07, which is considered slightly low relative to its 30-day fair value range of $9.92 to $11.45. From a valuation perspective, the stock is trading at a discount (Forward PE: 6.7) compared to its historical average (8.9). Remarkably, the market is currently pricing in an annual earnings decline of 9.0% over the next few years. This pessimistic expectation contrasts with the company's recent 200% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PHR is in a uptrend. Immediate support is located at $9.65, while resistance sits at $10.50.
Market Sentiment: PHR scores 67/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $14.07 (+39.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PHR is in a uptrend. Immediate support is located at $9.65, while resistance sits at $10.50.
Market Sentiment: PHR scores 67/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $14.07 (+39.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$9.92 -
$11.45
Company Quality Score
69/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
92.3%
Protect Your Profits
Holding PHR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (67/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 39.7% below Wall St target ($14.07)
- CAUTION: Bottoming setup, but lagging the sector by 23% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$9.92 -
$11.45
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
±$0.84
(8.4%)
Support & Resistance Levels
Support Level
$9.65
Resistance Level
$10.50
Current Trend
Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.69
Wall Street Target
$14.07
(+39.7%)
Revenue Growth (YoY)
10.4%
Earnings Growth (YoY)
200.0%
Profit Margin
2.1%
Valuation Discount vs History
-9.0% cheaper
PE vs Historical
6.7 vs 8.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-9.0%
(market-implied from PE analysis)
1-Year Target
$9.16
(-9%)
2-Year Target
$8.34
(-17%)
3-Year Target
$7.59
(-25%)
3-Yr Target (if PE normalizes)
(PE: 7→9)
$10.10
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: 29.2%)
$66.18
(+557%)
Base:
(SPY PE: 6.7, Growth: 29.2%)
$21.69
(+115%)
Bear:
(PE: 5.7, Growth: 29.2%)
$18.44
(+83%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (12x PE), but valuation improves significantly next year (7x PE) as earnings recover.
Forward PE: 12.02 | Forward EPS (Implied): $0.84
Bull Case
$12.16
(+21%)
Analyst growth 15.0%, PE expands to 12.6
Base Case
$10.07
(0%)
Market implied 0.0%, PE stable at 12.0
Bear Case
$7.70
(-24%)
Severe decline -15.0%, PE contracts to 10.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 6.7 to 8.9
Stabilization Target:
$13.40
(+33.1%)
PE Expansion Potential:
+33.1%
Share & Embed Analysis
Last updated: October 02, 2026 9:23 PM ET
Data refreshes hourly during market hours. Next update: 10:23 PM
Data refreshes hourly during market hours. Next update: 10:23 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PHR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Allison C Hoffman
SELL
6176 shares
2026-04-20
Yvonne Hui
SELL
1327 shares
2026-04-17
Yvonne Hui
SELL
10063 shares
2026-04-16
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 67 BUY |
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$297 | 37 SELL |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 60 BUY |
|
EVH
Evolent Health Inc |
STRONG BUY
14 analysts |
$6 | 54 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$119 | 52 HOLD |
Advanced PHR Option Strategies
Professional options setups generated by AI based on today's PHR price and gamma walls.
